N/A
N=28
Wound Dressings for Hidradenitis Suppurativa
Hidradenitis Suppurativa
Bottom Line
View on ClinicalTrials.gov: NCT04194541 ↗Enrolled (actual)
28
Serious AEs
0.0%
Results posted
Mar 2023
Primary outcome: Primary: Dermatology Life Quality Index (DLQI) Scores — 15.5; 12.5 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Cutimed Sorbact Hydroactive B wound dressing (Device); Cutimed Siltect wound dressing (Device); Sorbion Sana multi-star wound dressing (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Miami
- Primary completion
- Mar 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Dermatology Life Quality Index (DLQI) Scores |
15.5; 12.5 | — |
| SECONDARY Average Pain as Assessed by the Numerical Rating Scale (NRS) |
6.5; 5 | — |
| SECONDARY Maximal Pain as Assessed by the Numerical Rating Scale (NRS) |
7.5; 6.5 | — |
| SECONDARY Sleep Rating |
4; 3.5 | — |
| SECONDARY Drainage Rating |
3.06; 3.6 | — |
| SECONDARY Odor Rating |
2.5; 2.5 | — |
| SECONDARY Number of Participants at Each Hidradenitis Suppurativa Physician Global Assessment (HS-PGA) Grading |
0; 0; 0; 10; 3; 1 | — |
| SECONDARY Average Frequency of Dressing Changes |
1 | — |
| SECONDARY Number of Participants Reporting Overall Dressing Preference for Specific Body Part |
9; 13; 6 | — |
| SECONDARY Number of Participants Reporting Dressing Preference for Each Specific Body Part |
7; 8; 4; 1; 3; 2 | — |
Summary
The primary purpose of this research is to determine how the types of wound dressings affect quality of life for people with Hidradenitis Suppurativa (HS).
Eligibility Criteria
Inclusion Criteria
- Men and women ≥18 years of age
- Diagnosed with Hidradenitis Suppurativa (all stages of disease) by Dermatologist
- Presence of at least one lesion with active drainage
- Willing and able to provide informed consent
Exclusion Criteria
- Subjects younger than 18-years-old.
- Prisoners
- Pregnant or lactating women
- Adults unable to consent
Data sourced from ClinicalTrials.gov (NCT04194541). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.